Maoyan Entertainment (HKG:1896)

Market Cap	8.54B
Revenue (ttm)	4.34B
Net Income (ttm)	193.58M
Shares Out	1.15B
EPS (ttm)	0.17
PE Ratio	43.93
Forward PE	13.39
Dividend	0.32 (4.00%)
Ex-Dividend Date	Jun 27, 2025

Volume	4,720,539
Average Volume	10,489,268
Open	7.47
Previous Close	7.42
Day's Range	7.35 - 7.47
52-Week Range	5.56 - 9.95
Beta	1.11
RSI	43.15
Earnings Date	Aug 15, 2025

About Revance Therapeutics

Maoyan Entertainment, an investment holding company, operates a platform in the entertainment industry in the People’s Republic of China. The company offers online movie and entertainment event ticketing, entertainment content, advertising, and other services. It also provides movie distribution and promotion, movie production and investment, and licensing of broadcasting rights of television series; online ordering of in-cinema food and beverage, sale of IP-centric movie merchandise, and movie ticket membership subscriptions for cinemas; and p...

• Industry: Internet Content & Information
• Sector: Communication Services
• Founded: 2012
• Employees: 917
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1896

Financial Performance

In 2024, Maoyan Entertainment's revenue was 4.08 billion, a decrease of -14.19% compared to the previous year's 4.76 billion. Earnings were 181.91 million, a decrease of -80.02%.